CANCER RELATED COGNITIVE DECLINE

Clinical trials for CANCER RELATED COGNITIVE DECLINE explained in plain language.

Never miss a new study

Get alerted when new CANCER RELATED COGNITIVE DECLINE trials appear

Sign up with your email to follow new studies for CANCER RELATED COGNITIVE DECLINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug aims to shield cancer patients from Chemo's hidden damage

Disease control Recruiting now

This early-stage study is testing if a drug called azeliragon can protect women's hearts and thinking skills during chemotherapy for early breast cancer. Researchers want to see if adding azeliragon to standard chemo is safe and can reduce heart damage and 'chemo brain.' The tria…

Matched conditions: CANCER RELATED COGNITIVE DECLINE

Phase: PHASE1, PHASE2 • Sponsor: Georgetown University • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

CANCER RELATED COGNITIVE DECLINE

Get alerted when new CANCER RELATED COGNITIVE DECLINE trials appear

New drug aims to shield cancer patients from Chemo's hidden damage